Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 1
1972 1
1973 1
1974 2
1975 2
1976 4
1977 1
1978 3
1979 4
1980 3
1981 2
1982 7
1983 4
1984 13
1985 19
1986 16
1987 42
1988 55
1989 72
1990 86
1991 73
1992 94
1993 100
1994 101
1995 107
1996 109
1997 144
1998 121
1999 128
2000 122
2001 155
2002 159
2003 223
2004 230
2005 198
2006 254
2007 288
2008 294
2009 331
2010 301
2011 312
2012 330
2013 357
2014 370
2015 375
2016 395
2017 386
2018 392
2019 364
2020 398
2021 341
2022 337
2023 395
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

7,968 results

Results by year

Filters applied: . Clear all
Page 1
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Bahadoram S, et al. G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3. G Ital Nefrol. 2022. PMID: 35819037 Free article. Review.
Renal cell carcinoma (RCC) is the most common type of urogenital cancer. ...The most common type of RCC, based on histological and molecular subtypes, is clear cell carcinoma which occurs frequently due to mutations in the VHL gene. ...
Renal cell carcinoma (RCC) is the most common type of urogenital cancer. ...The most common type of RCC, based on histo
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J, Ohashi R, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, Menon S, Netto GJ, Raspollini MR, Rubin MA, Tan PH, Tickoo SK, Tsuzuki T, Turajlic S, Zhou M, Srigley JR, Moch H. Lobo J, et al. Histopathology. 2022 Oct;81(4):426-438. doi: 10.1111/his.14700. Epub 2022 Jun 10. Histopathology. 2022. PMID: 35596618 Review.
The 5th edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems contains relevant revisions and introduces a group of molecularly defined renal tumour subtypes. Herein we present the World Health Organization (WHO) 2022 perspectives on papillar …
The 5th edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems contains relevant revisions and introduces a gr …
Comprehensive review of chromophobe renal cell carcinoma.
Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L. Garje R, et al. Crit Rev Oncol Hematol. 2021 Apr;160:103287. doi: 10.1016/j.critrevonc.2021.103287. Epub 2021 Mar 19. Crit Rev Oncol Hematol. 2021. PMID: 33753250 Free article. Review.
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with distinct biology compared to other kidney cancer subtypes. ...ChRCC is characterized by chromosomal aneuploidy, TP53, PTEN, and mitochondrial gene mutations. Though the
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with distinct biology compared to
Renal cell carcinoma.
Rini BI, Campbell SC, Escudier B. Rini BI, et al. Lancet. 2009 Mar 28;373(9669):1119-32. doi: 10.1016/S0140-6736(09)60229-4. Epub 2009 Mar 5. Lancet. 2009. PMID: 19269025 Free article. Review.
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. ...The effectiveness of immunotherapy, although previously widely used …
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical an …
Renal Cell Carcinoma: Diagnosis and Management.
Gray RE, Harris GT. Gray RE, et al. Am Fam Physician. 2019 Feb 1;99(3):179-184. Am Fam Physician. 2019. PMID: 30702258 Free article. Review.
Kidney cancer is one of the 10 most common cancers in the United States with 90% being attributed to renal cell carcinoma. Men, especially black men, are more likely to be affected than women. Renal masses, either cystic or solid, are best detected wit …
Kidney cancer is one of the 10 most common cancers in the United States with 90% being attributed to renal cell carcinoma
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.
Petejova N, Martinek A. Petejova N, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):183-94. doi: 10.5507/bp.2015.050. Epub 2015 Nov 3. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. PMID: 26558360 Free article. Review.
BACKGROUND AND AIMS: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. ...Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a kno …
BACKGROUND AND AIMS: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. ...Ap …
Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T, Rossi SH, Stewart GD. Klatte T, et al. World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30. World J Urol. 2018. PMID: 29713755 Review.
PURPOSE: Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of patients develop tumour recurrence. ...
PURPOSE: Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of patients develop tumour re …
Papillary renal cell carcinoma: Review.
Mendhiratta N, Muraki P, Sisk AE Jr, Shuch B. Mendhiratta N, et al. Urol Oncol. 2021 Jun;39(6):327-337. doi: 10.1016/j.urolonc.2021.04.013. Epub 2021 May 24. Urol Oncol. 2021. PMID: 34034966 Review.
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of renal cell carcinomas. ...In this review, we summarize the contemporar …
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma
What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R, Siadat F, Trpkov K. Alaghehbandan R, et al. Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. Epub 2023 Jan 16. Pathologica. 2022. PMID: 36645398 Free PMC article. Review.
A major change in this edition is the grouping of renal tumours into broader categories that include "clear cell renal tumours", "papillary renal tumours", "oncocytic and chromophobe renal tumours", "collecting duct tumours" as well as ad …
A major change in this edition is the grouping of renal tumours into broader categories that include "clear cell renal
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM, Ricketts CJ. Linehan WM, et al. Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5. Nat Rev Urol. 2019. PMID: 31278395 Review.
The Cancer Genome Atlas (TCGA) characterized the somatic genetic and genomic alterations in renal cell carcinoma (RCC) encompassing the major RCC histological subtypes, including clear cell RCC (ccRCC), papillary RCC (pRCC) and chromophobe RCC ( …
The Cancer Genome Atlas (TCGA) characterized the somatic genetic and genomic alterations in renal cell carcinoma (RCC) …
7,968 results